The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial

BACKGROUND: Recent circumstantial evidence suggests increasing number of Iranian patients with cutaneous leishmaniasis (CL) who are unresponsive to meglumine antimoniate (MA), the first line of treatment in Iran. Oral meltifosine was previously reported to be effective in visceral leishmaniasis as w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayyebi, Masoumeh, Darchini-Maragheh, Emadodin, Layegh, Pouran, Kiafar, Bita, Goyonlo, Vahid Mashayekhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034709/
https://www.ncbi.nlm.nih.gov/pubmed/33739976
http://dx.doi.org/10.1371/journal.pntd.0009241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034709/
https://www.ncbi.nlm.nih.gov/pubmed/33739976
http://dx.doi.org/10.1371/journal.pntd.0009241

Ejemplares similares